313 related articles for article (PubMed ID: 19083009)
1. Imatinib use during pregnancy and breast feeding: a case report and review of the literature.
Ali R; Ozkalemkas F; Kimya Y; Koksal N; Ozkocaman V; Gulten T; Yorulmaz H; Tunali A
Arch Gynecol Obstet; 2009 Aug; 280(2):169-75. PubMed ID: 19083009
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy under treatment of imatinib and successful labor in a patient with chronic myelogenous leukemia (CML). Outcome of discontinuation of imatinib therapy after achieving a molecular remission.
Ali R; Ozkalemkaş F; Ozçelik T; Ozkocaman V; Ozan U; Kimya Y; Köksal N; Gülten T; Yakut T; Tunali A
Leuk Res; 2005 Aug; 29(8):971-3. PubMed ID: 15978950
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy complicated with chronic myelogeneous leukemia (CML) successfully treated with imatinib: a case report.
Buyukbayrak EE; Ergen B; Karsidag YK; Kars B; Turan C; Argon D
Arch Gynecol Obstet; 2008 Aug; 278(2):161-3. PubMed ID: 18193246
[TBL] [Abstract][Full Text] [Related]
4. Imatinib mesylate and metabolite concentrations in maternal blood, umbilical cord blood, placenta and breast milk.
Russell MA; Carpenter MW; Akhtar MS; Lagattuta TF; Egorin MJ
J Perinatol; 2007 Apr; 27(4):241-3. PubMed ID: 17377606
[TBL] [Abstract][Full Text] [Related]
5. [Clinical analysis about the management and the perinatal outcomes of pregnancy with chronic myeloid leukemia].
Wang DP; Liang MY; Zhang XH; Wang SM
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):735-9. PubMed ID: 21176552
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy among patients with chronic myeloid leukemia treated with imatinib.
Ault P; Kantarjian H; O'Brien S; Faderl S; Beran M; Rios MB; Koller C; Giles F; Keating M; Talpaz M; Cortes J
J Clin Oncol; 2006 Mar; 24(7):1204-8. PubMed ID: 16446320
[TBL] [Abstract][Full Text] [Related]
7. Twin pregnancy in a patient of chronic myeloid leukemia on imatinib therapy.
Meera V; Jijina F; Shrikande M; Madkaikar M; Ghosh K
Leuk Res; 2008 Oct; 32(10):1620-2. PubMed ID: 18420270
[TBL] [Abstract][Full Text] [Related]
8. Divergent clinical outcome in two CML patients who discontinued imatinib therapy after achieving a molecular remission.
Mauro MJ; Druker BJ; Maziarz RT
Leuk Res; 2004 May; 28 Suppl 1():S71-3. PubMed ID: 15036945
[TBL] [Abstract][Full Text] [Related]
9. BCR-ABL transcripts are not detected in cord blood or the peripheral blood of the newborn child whose mother developed chronic myeloid leukemia while pregnant.
Salomon O; Tohami T; Trakhtenbrot L; Meirov R; Kneller A; Berkowitz M; Nagler A; Sivan E; Goldman JM; Rechavi G; Amariglio N
Leuk Res; 2010 Feb; 34(2):e78-81. PubMed ID: 19640586
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic effects of imatinib on chronic myeloid leukemia in different phases and the factors affecting the effects].
Zou WY; Xu DR; Su C; Li J; Luo SK
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1660-2. PubMed ID: 18819894
[TBL] [Abstract][Full Text] [Related]
11. Persistence of molecular remission throughout pregnancy in CML after imatinib.
Sorà F; De Matteis S; Bajer J; D'alò F; Leone G; Sica S
Leuk Res; 2009 Jun; 33(6):e6-7. PubMed ID: 18937976
[No Abstract] [Full Text] [Related]
12. Molecular response to imatinib in patient with Ph negative p190 BCR-ABL transcript positive chronic myeloid leukemia with cyclic leukocytosis.
Radojkovic M; Ristic S; Pavlovic S; Colovic M
Leuk Res; 2009 Jun; 33(6):e10-2. PubMed ID: 19091403
[TBL] [Abstract][Full Text] [Related]
13. Chronic myelocytic leukemia in pregnancy: a case report describing successful treatment using multimodal therapy.
Eskander RN; Tarsa M; Herbst KD; Kelly TF
J Obstet Gynaecol Res; 2011 Nov; 37(11):1731-3. PubMed ID: 21790885
[TBL] [Abstract][Full Text] [Related]
14. Sudden extramedullary T-lymphoblastic blast crisis in chronic myelogenous leukemia: a nonrandom event associated with imatinib?
Kim AS; Goldstein SC; Luger S; Van Deerlin VM; Bagg A
Am J Clin Pathol; 2008 Apr; 129(4):639-48. PubMed ID: 18343792
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults.
Menon-Andersen D; Mondick JT; Jayaraman B; Thompson PA; Blaney SM; Bernstein M; Bond M; Champagne M; Fossler MJ; Barrett JS
Cancer Chemother Pharmacol; 2009 Jan; 63(2):229-38. PubMed ID: 18398615
[TBL] [Abstract][Full Text] [Related]
16. Imatinib plasma trough levels in chronic myeloid leukaemia: results of a multicentre study CSTI571AIL11TGLIVEC.
Koren-Michowitz M; Volchek Y; Naparstek E; Gavish I; Levi I; Rowe JM; Shimoni A; Nagler A
Hematol Oncol; 2012 Dec; 30(4):200-5. PubMed ID: 22241698
[TBL] [Abstract][Full Text] [Related]
17. Significance of myelofibrosis in early chronic-phase, chronic myelogenous leukemia on imatinib mesylate therapy.
Kantarjian HM; Bueso-Ramos CE; Talpaz M; O'Brien S; Giles F; Faderl S; Wierda W; Rios MB; Shan J; Cortes J
Cancer; 2005 Aug; 104(4):777-80. PubMed ID: 15971197
[TBL] [Abstract][Full Text] [Related]
18. Response to treatment in women with chronic myeloid leukemia during pregnancy and after delivery.
Klamová H; Marková M; Moravcová J; Sisková M; Cetkovský P; Machová Poláková K
Leuk Res; 2009 Nov; 33(11):1567-9. PubMed ID: 19580997
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of antileukaemic effects of rapamycin in patients with imatinib-resistant chronic myeloid leukaemia.
Sillaber C; Mayerhofer M; Böhm A; Vales A; Gruze A; Aichberger KJ; Esterbauer H; Pfeilstöcker M; Sperr WR; Pickl WF; Haas OA; Valent P
Eur J Clin Invest; 2008 Jan; 38(1):43-52. PubMed ID: 18173550
[TBL] [Abstract][Full Text] [Related]
20. Cellular and molecular responses of Saudi chronic myeloid leukaemia patients to imatinib (STI-571): ten year experience.
Alenzi FQ; Al-Amri AM; Alanazi FG; Tamimi W; Alanazi A; Alenezy AK; Al-Swailmi F
J Ayub Med Coll Abbottabad; 2012; 24(2):122-8. PubMed ID: 24397072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
